4-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrazin-2-ylmethyl)pyrrolo[3,2-d]pyrimidine-2,4-diamine
C15H15N9O — CID 118335026
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrazin-2-ylmethyl)pyrrolo[3,2-d]pyrimidine-2,4-diamine
4-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrazin-2-ylmethyl)pyrrolo[3,2-d]pyrimidine-2,4-diamine (PubChem CID 118335026) has the molecular formula C15H15N9O and a molecular weight of 337.35 g/mol. Its IUPAC name is 4-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrazin-2-ylmethyl)pyrrolo[3,2-d]pyrimidine-2,4-diamine.
Molecular Properties
| Compound Name | 4-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrazin-2-ylmethyl)pyrrolo[3,2-d]pyrimidine-2,4-diamine |
|---|---|
| PubChem CID | 118335026 |
| Molecular Formula | C15H15N9O |
| Molecular Weight | 337.35 g/mol |
| Exact Mass | 337.14 |
| IUPAC Name | 4-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-5-(pyrazin-2-ylmethyl)pyrrolo[3,2-d]pyrimidine-2,4-diamine |
| SMILES | Cc1nc(CNc2nc(N)nc3ccn(Cc4cnccn4)c23)no1 |
| InChI | InChI=1S/C15H15N9O/c1-9-20-12(23-25-9)7-19-14-13-11(21-15(16)22-14)2-5-24(13)8-10-6-17-3-4-18-10/h2-6H,7-8H2,1H3,(H3,16,19,21,22) |
| InChIKey | BDEVYHUVIYWZLD-UHFFFAOYSA-N |
| XLogP | 1.16 |
| TPSA | 133.46 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 337.35 |
| LogP ≤ 5 | 1.16 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118335026 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.